Stephen Elledge (Emmanuel Ording, Harvard)
Stephen Elledge's Harvard lab again proves fruitful with the launch of high-throughput antibody startup
After working with esteemed Harvard professor Stephen Elledge to launch TCR-focused TScan Therapeutics three years ago, the Longwood Fund approached the scientist last spring about …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
